MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2018 International Congress

    Use of safinamide: A clinical practice review of 2 year experience

    C. Borrue-Fernandez (San Sebastian Reyes, Spain)

    Objective: Review the clinical use, efectivity and side efects in a population based cohort. Background: Safinamide is an oral, once a day adjunctive therapy for…
  • 2018 International Congress

    CLOVER-DBS: A Prospective, Multi-center Clinical Study with Blinding to Evaluate a Closed Loop Programming Algorithm for Directional Leads Based on External Feedback

    A. Kuehn, G. Wenzel, C. Bruecke, L. Juarez Paz, K. Wynants, H. Scholtes, D. Blum (Berlin, Germany)

    Objective: To assess the feasibility and efficacy of a novel closed-loop programming algorithm (CLPA) for directional lead deep brain stimulation (DBS) based on objective feedback…
  • 2018 International Congress

    Design of a Phase 3 Efficacy and Safety Trial of Accordion Pill™ Carbidopa/Levodopa for Parkinson’s Disease (PD) Patients Experiencing Motor Fluctuations

    P. LeWitt, R. Gendreau, J. Meckler, N. Navon (West Bloomfield, MI, USA)

    Objective: To review the design and unique features of an ongoing phase 3 trial of a gastric-retentive formulation of carbidopa/levodopa (CD/LD), the Accordion Pill™ (AP),…
  • 2018 International Congress

    Oral treatment with sphingosine-1-phosphate receptors modulator prevents Parkinson symptoms concomitantly to reduced brain inflammation in MPTP mouse models

    M. Cyr, E. Pépin, G. Massicotte (Trois-Rivieres, QC, Canada)

    Objective: Here we explore the efficacy of an oral treatment with Fingolimod (FTY720), a selective sphingosine-1-phosphate receptors modulator, to prevent MPTP induced nigrostriatal loss and…
  • 2018 International Congress

    Levodopa Effect on Dual-Tasking in Freezing of Gait in Parkinson’s Disease

    E. Bayram, J. Longhurst, S. Banks, Z. Mari, B. Bluett (Las Vegas, NV, USA)

    Objective: To assess the effect of levodopa on dual-tasking in situations triggering freezing of gait (FOG) in Parkinson’s disease (PD). Background: The frequency and severity…
  • 2018 International Congress

    The effects of treadmill training augmented by virtual reality on postural control and freezing of gait in Parkinson’s disease

    E. Bekkers, A. Mirelman, S. Del Din, L. Avanzino, F. Nieuwhof, J. Hausdorff, A. Nieuwboer (Leuven, Belgium)

    Objective: To investigate whether treadmill training with virtual reality is beneficial both for Parkinson’s disease patients with and without freezing of gait (FOG) to address…
  • 2018 International Congress

    Correlation between severity of disease, spatio-temporal variables, and kinematic variables during forward and backward walking

    M. Son, C. Youm, M. Lee, H. Park (Busan, Republic of Korea)

    Objective: The purpose of this study was to analyze the correlation between disease severity and variable by using spatio-temporal and kinematic variables during forward and…
  • 2018 International Congress

    Effects of Intensive Voice and Articulation Treatments on Voice Quality in Parkinson’s disease

    J. Spielman, L. Ramig, K. Freeman, A. Halpern, Y. Maryn (Denver, CO, USA)

    Objective: This study evaluated the impact of voice treatment (LSVT LOUD) and articulation treatment (LSVT ARTIC) on voice quality in Parkinson's disease (PD) measured by…
  • 2018 International Congress

    Combined administration of A2A receptor antagonist and 5-HT1A/1B receptor agonist reverses neuroinflammation in the 6-OHDA model of Parkinson’s disease

    A. Pinna, G. Costa, M. Serra, M. Morelli (Monserrato (CA), Italy)

    Objective: To investigate whether in a model of Parkinson's Disease (PD), an early treatment with the serotonin 5-HT1A/1B receptor agonist eltoprazine and the adenosine A2A…
  • 2018 International Congress

    Clinical trial protocol: Restitution of oral transport, penetration and aspiration with nigral stimulation in Parkinson’s disease?

    A. Schoellmann, L. Stoll, B. Hobl, C. Meisner, A. Gharabaghi, D. (Tuebingen, Germany)

    Objective: In this randomized controlled clinical trial, we aim to characterize the differential effect of subthalamic nucleus (STN) or subthalamic nucleus and substantia nigra pars…
  • « Previous Page
  • 1
  • …
  • 1228
  • 1229
  • 1230
  • 1231
  • 1232
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley